Journal of Pharmaceutical Research International

Introduction: Urinary bladder cancer is a global health problem. Carcinosarcoma of bladder is a very rare abnormal growth of cells and tissues called as tumors and it consist of malignant epithelial and sarcomatoids components. It mostly occurs at aging. Presentation of disease with hematuria i.e. blood in urine and painful urination i.e. dysuria. Pelvic radiation and cyclophosphamide therapy are the risk factors responsible for carcinoma of bladder.

Clinical Findings: Severe abdominal pain, fever (Temperature- 100⁰ F), weakness, Anemia (Hemoglobin- 10.6gm %).

Diagnostic Evaluation: Blood test Hemoglobin -10.6 gram %, Total Red blood cell count- 3.4 million/cumm, Hematocrit- 21.45, Total White blood cells count- 12,000 per microliter. In ultrasonography it was found that, a mass present on the right lateral wall of the urinary bladder.

Therapeutic Intervention: Hemoglobin was raised by blood transfusion, Inj. Ceftriaxone 1gm Intravenously BD, Inj. Pantoprazole 40 mg Intravenously BD, radiation therapy and chemotherapy.

Outcome: As compared to prior condition patient’s present condition show improvement. Fever was reduced and relieved abdominal pain by treatment and procedure transurethral resection of bladder tumor. With the help of blood transfusion Hemoglobin % increased from 10.6 to 11.5gm%.

Conclusion: My client was admitted to female surgery ward, at Acharya Vinoba Bhave Rural Hospital Sawangi (Meghe), Wardha with an unknown case of Ca bladder. On admission her condition was poor. So on clinical manifestation, specific and routine investigation was done and after proper treatment her condition was found improved than previous. Here we have to emphasize on early diagnosis and proper treatment strategies helps to improve patient’s prognosis. It also helps to prevent morbidity and mortality.